Phio Pharmaceuticals Corp. Profile Avatar - Palmy Investing

Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates…

Biotechnology
US, Marlborough [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of PHIO's Analysis
CIK: 1533040 CUSIP: 71880W303 ISIN: US71880W4024 LEI: - UEI: -
Secondary Listings
PHIO has no secondary listings inside our databases.